"Drug Delivery Systems" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity.
Descriptor ID |
D016503
|
MeSH Number(s) |
E02.319.300
|
Concept/Terms |
Drug Delivery Systems- Drug Delivery Systems
- Delivery System, Drug
- Delivery Systems, Drug
- Drug Delivery System
- System, Drug Delivery
- Systems, Drug Delivery
- Drug Targeting
- Drug Targetings
- Targeting, Drug
- Targetings, Drug
|
Below are MeSH descriptors whose meaning is more general than "Drug Delivery Systems".
Below are MeSH descriptors whose meaning is more specific than "Drug Delivery Systems".
This graph shows the total number of publications written about "Drug Delivery Systems" by people in this website by year, and whether "Drug Delivery Systems" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
2000 | 2 | 1 | 3 |
2001 | 2 | 0 | 2 |
2002 | 2 | 0 | 2 |
2003 | 1 | 2 | 3 |
2004 | 2 | 4 | 6 |
2005 | 2 | 5 | 7 |
2006 | 3 | 4 | 7 |
2007 | 5 | 3 | 8 |
2008 | 4 | 3 | 7 |
2009 | 3 | 8 | 11 |
2010 | 2 | 5 | 7 |
2011 | 5 | 4 | 9 |
2012 | 6 | 4 | 10 |
2013 | 3 | 6 | 9 |
2014 | 3 | 1 | 4 |
2015 | 8 | 4 | 12 |
2016 | 7 | 2 | 9 |
2017 | 6 | 2 | 8 |
2018 | 6 | 2 | 8 |
2019 | 2 | 2 | 4 |
2020 | 0 | 3 | 3 |
2021 | 2 | 4 | 6 |
2022 | 2 | 3 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Delivery Systems" by people in Profiles.
-
Suprachoroidal Drug Delivery for Clinicians: Anatomic Principles, Clinical Data in Uveitis, and Future Directions. Ophthalmic Surg Lasers Imaging Retina. 2022 07; 53(7):361-366.
-
Tumor-Activatable Nanoparticles Target Low-Density Lipoprotein Receptor to Enhance Drug Delivery and Antitumor Efficacy. Adv Sci (Weinh). 2022 08; 9(24):e2201614.
-
Harnessing the Therapeutic Potential of Biomacromolecules through Intracellular Delivery of Nucleic Acids, Peptides, and Proteins. Adv Healthc Mater. 2022 06; 11(12):e2102600.
-
Nanomechanical testing in drug delivery: Theory, applications, and emerging trends. Adv Drug Deliv Rev. 2022 04; 183:114167.
-
Pump IT Up-Perioperative Care of Patients With Intrathecal Drug Delivery Systems. Anesth Analg. 2022 01 01; 134(1):32-34.
-
Size-Dependent Drug Loading, Gene Complexation, Cell Uptake, and Transfection of a Novel Dendron-Lipid Nanoparticle for Drug/Gene Co-delivery. Biomacromolecules. 2021 09 13; 22(9):3746-3755.
-
Immunoengineering approaches for cytokine therapy. Am J Physiol Cell Physiol. 2021 08 01; 321(2):C369-C383.
-
Development of CD133 Targeting Multi-Drug Polymer Micellar Nanoparticles for Glioblastoma - In Vitro Evaluation in Glioblastoma Stem Cells. Pharm Res. 2021 Jun; 38(6):1067-1079.
-
Sunitinib-Loaded Chondroitin Sulfate Hydrogels as a Novel Drug-Delivery Mechanism for the Treatment of Pancreatic Neuroendocrine Tumors. Ann Surg Oncol. 2021 Dec; 28(13):8532-8543.
-
Receptor and Molecular Targets for the Development of Novel Opioid and Non-Opioid Analgesic Therapies. Pain Physician. 2021 03; 24(2):153-163.